CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, March 31, 2025 /PRNewswire/ -- Harbour BioMed ('HBM' or the 'Company'; ...

Vertex continues to develop type 1 diabetes therapy, zimislecel, which is being investigated in a Phase III trial.

HAS Healthcare Advanced Synthesis SA ("HAS"), a leading international developer and producer of active pharmaceutical ingredients (APIs), high-potency active pharmaceutical ingredients (HPAPIs), and ...

The e-commerce sector in India is expected to witness the highest salary hike in 2025, with hikes surpassing 10%, said a ...

Non-profit organisations provide an alternative to rescue stalled orphan drugs for biotechs struggling against a lethargic ...

BOC Sciences adds to its participation agenda the prestigious Drug Discovery Chemistry 2025 Conference (April 14-17, 2025), which will be a hybrid event taking place in San Diego, CA, and will offer ...

Rocket Mortgage and Redfin are powerful brands and Dan Gilbert's company insists a streamlined process they plan to create ...

Jennifer Butler, chief commercial officer of Pleio, discusses misinformation's threat to public health, where patients are ...

The Elite 8 of Memphis-area pizzerias has been decided. You can vote now to see your favorite pie advance to the Final Four ...

Aspire Pharma Ltd is a global life sciences business, based in the UK, devoted to delivering true value to patients, ...

OSI Systems, NVE, Virpax Pharmaceuticals, Biodexa Pharmaceuticals, Clene, and Clene are the seven Nanotechnology stocks to watch today, according to MarketBeat’s stock screener tool. Nanotechnology ...

The Philippine Economic Zone Authority (PEZA) said Friday that a new ecozone in Tarlac will host the country’s first ...